Next generation mRNA vaccines
FUTR BIO is a biotechnology company focused on developing next generation mRNA vaccines to prevent and cure diseases such as infections and cancer.
espaçamento
Our technology
At FUTR BIO, we believe we can take mRNA vaccines to the next level. Our proprietary vaccine technology incorporates natural UTRs and molecular boosters to provide superior immune responses against infectious diseases and cancer.
Cutting-edge science transformed into better vaccines.
- Nature-inspired
- Unique
- Flexible
- Customizable
- Precise
- Faster protection
Innovative mRNA Vaccines
To transform cutting edge science into effective medicines, we teamed up to design an innovative mRNA vaccine platform to fight infectious diseases and cancer. Inspired by nature, we developed mRNA vaccine technologies to induce faster, regulated and durable immune responses by fine tune control of the mammalian immune system.
Meet the team
André Báfica, MD, PhD
Scientific Advisor & Co-founder
Dr. Báfica has led scientific discoveries in the field of immunology and human pathogens, contributing to adjuvants and vaccine development. Dr. Báfica had developed solid scientific work at world class institutions such as the National Institutes of Health, Rockefeller University and New York University. By engaging in inspiring leadership programmes, Dr. Báfica was a nominated member of the Brazilian Academy of Sciences and the National Academy of Medicine. His contributions to science were recognized by his international Awards such the Howard Hughes Medical Institute Early Career Investigator Competition and GRIP R01 NIH. Dr. Báfica is a member of the Halo Team, an United Nations Verified Initiative helping end the pandemic. Dr. Báfica is an associate professor at UFSC and a member of the Halo Team, an United Nations Verified Initiative helping end the pandemic.
Daniel Mansur, PhD
Scientific Advisor & Co-founder
Dr. Mansur’s breakthrough research in the field of molecular virology has contributed to unraveling innate recognition pathways of DNA and RNA viruses. Prior to forming his group in Brazil Dr. Daniel has worked in world class institutions such as Imperial College London and University of Cambridge. Dr. Daniel secured funding for vaccine development and flavivirus biology from international sources such as GSK and the Newton Fund/ Royal Society. Dr. Mansur is a Brazilian leader in molecular virology and development of gene editing tools such as CRISPR-based molecular tools to understand microbial pathogenesis. Dr. Mansur is an associate professor at UFSC and a leader in molecular virology and development of gene editing tools such as CRISPR-based molecular tools to understand microbial pathogenesis.
Aline Murad, PhD
Scientist (Molecular Biology). Dr. Aline is a structural biologist by training elucidating the molecular mechanisms of pathogen vitamin biosynthesis pathways.
Daniel Mendes, PhD
Scientist (Immunology). Dr. Daniel has worked unraveling the immunological mechanisms in several disease models including the interaction of vaccines and the immune system.
Greicy Dias, PhD
Scientist (Molecular Biology). Dr. Greicy is an expert on molecular and cellular biology of infectious organisms including parasites and viruses.
Aline Murad, PhD
Scientist (Molecular Biology). Dr. Aline is a structural biologist by training elucidating the molecular mechanisms of pathogen vitamin biosynthesis pathways.
Daniel Mendes, PhD
Scientist (Immunology). Dr. Daniel has worked unraveling the immunological mechanisms in several disease models including the interaction of vaccines and the immune system.
Greicy Dias, PhD
Scientist (Molecular Biology). Dr. Greicy is an expert on molecular and cellular biology of infectious organisms including parasites and viruses.
Scientific Board
Charles N. Serhan, PhD, DSc
Scientific Advisor
Dr. Serhan is the Simon Gelman Professor of Anaesthesia (Biochemistry and Molecular Pharmacology) at Harvard Medical School and Professor of Oral Medicine, Infection and Immunity at Harvard School of Dental Medicine. He is Director of the Center for Experimental Therapeutics and Reperfusion Injury at Brigham and Women’s Hospital. He has received several awards including an NIH MERIT award (2000) and has delivered > 50 keynote and plenary lectures. Among these, 2008 William Harvey Outstanding Scientist Medal and AAAS Fellow in 2011. In 2010, he received the Society for Leukocyte Biology Bonazinga Award for outstanding research on leukocytes, The American College of Rheumatology Hench (Nobel Laureate) Award Lecture in 2011 and is a Mérieux 2013 Laureate. In 2016, he received the IUBMB Lecture Metal and the Ross Prize in Molecular Medicine. In 2017, he received the International Eicosanoid Research Foundation’s Lifetime Achievement Award and the American Society of Investigative Pathology (ASIP) 2018 Rous Whipple Award.
Ruslan Medzhitov, PhD
Scientific Advisor
Dr. Medzhitov is a professor of immunobiology at Yale School of Medicine, a member of Yale Cancer Center, and a Howard Hughes Medical Institute investigator. His research focuses on the analysis of the innate immune system, inflammatory response, innate control of the adaptive immunity, and host-pathogen interactions. He has received the William Coley Award for Distinguished Research in Basic and Tumor Immunology from the Cancer Research Institute, a Master of Arts Privatum at Yale University, the Emil von Behring Award, AAI-BD Biosciences Investigator Award, a doctorate honoris Causa at the University of Munich, the Blavatnik Award for Young Scientists from the New York Academy of Arts and Sciences, the Howard Taylor Ricketts Award from the University of Chicago, the Lewis S. Rosenstiel Award for Distinguished Work in Basic Medical Research in 2010, and the Dickson Prize in 2019.
Pipeline
Contact Us
Espaço + Um
Rod. José Carlos Daux, 6977
Santo Antônio de Lisboa,
Florianópolis – SC
88050-000
futr@futr-bio.com